Functional fluorescently labeled bithiazole ΔF508-CFTR corrector imaged in whole body slices in mice

Bioconjugate Chemistry

Volumn 22, Issue 12, 2011, Pages 2593-2599

  Davison, Holly R ^a   Taylor, Stephanie ^b   Drake, Chris ^b   Phuan, Puay Wah ^b   Derichs, Nico ^b   Yao, Chenjuan ^b   Jones, Ella F ^b   Sutcliffe, Julie ^c   Verkman, A S ^b   Kurth, Mark J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c University of California Davis   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROPHORES; MAMMALS;

ACTIVITY ANALYSIS; BITHIAZOLE; CELLULARS; CYSTIC FIBROSIS; FLUORESCENCE IMAGING; GASTROINTESTINAL; INTRAVENOUS ADMINISTRATION; PROOF OF CONCEPT; STRUCTURE ACTIVITY; WHOLE-BODY;

FLUORESCENCE IMAGING;

BITHIAZOLE; FLUORESCENT DYE; THIAZOLE DERIVATIVE; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CELL TRANSPORT; CONTROLLED STUDY; FLUORESCENCE IMAGING; FROZEN SECTION; IN VIVO STUDY; INFRARED SPECTROSCOPY; LIVER; LUNG; MOUSE; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; SYNTHESIS; TISSUE SLICE; WHOLE BODY SLICE;

MUS;

EID: 84555186665     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc2004457     Document Type: Article

References (23)

1. Pilewski, J. M. and Frizzell, R. A. (1999) Role of CFTR in airway disease Physiol. Rev. 79, S215-S255
2. Sheppard, D. N. and Welsh, M. J. (1999) Structure and function of the CFTR chloride channel Physiol. Rev. 79, S23-S45
3. Denning, G. M., Anderson, M. P., Amara, J. F., Marshall, J., Smith, A. E., and Welsh, M. J. (1992) Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive Nature 358, 761-764
4. Lukacs, G. L., Mohamed, A., Kartner, N., Chang, A.-B., Riordan, J. R., and Grinstein, S. (1994) Conformational maturation of CFTR but not its mutant counterpart (ΔF508) occurs in the endoplasmic reticulum and requires ATP EMBO J. 13, 6076-6086
5. Kopito, R. R. (1999) Biosynthesis and degredation of CFTR Physiol. Rev. 79, S167-S173
6. Du, K., Sharma, M., and Lukacs, G. L. (2005) The ΔF508 cystic fibrosis impairs domain-domain interactions and arrests post-translational folding of CFTR Nat. Struct. Mol. Biol. 12, 17-25 (Pubitemid 40082912)
7. Carlile, G. W., Robert, R., Zhang, D., Teske, K. A., Luo, Y., Hanrahan, J. W., and Thomas, D. Y. (2007) Correctors of protein trafficking defects identified by a novel high-throughput screening assay ChemBioChem 8, 1012-1020 (Pubitemid 47189285)
8. Becq, F. (2006) On the discovery and development of CFTR chloride channel activators Cur. Pharm. Des. 12, 471-484
9. Van Goor, F., Straley, K. S., Cao, D., Gonzalez, J., Hadida, S., Hazelwood, A., Joubran, J., Knapp, T., Makings, L. R., Miller, M., Neuberger, T., Olson, E., Panchenko, V., Rader, J., Singh, A., Stack, J. H., Tung, R., Gootenhuis, P. D. J., and Negulescu, P. (2006) Rescue of deltaF508-CFTR trafficking and gating in human cystic fibrosis airway primary cultures by small molecules Am. J. Physiol. 290, L1117-L1130
10. Yang, H., Shelat, A. A., Guy, R. K., Gopinath, V. S., Ma, T., Du, K., Lukacs, G. L., Taddei, A., Folli, C., Pedemonte, N., Galietta, L. J. V., and Verkman, A. S. (2003) Nanomolar affinity small molecule correctors of defective ΔF508-CFTR chloride channel gating J. Biol. Chem. 278, 35079-35085 (Pubitemid 37102270)
11. Pedemonte, N., Lukacs, G. L., Du, K., Caci, E., Zegarra-Moran, O., Galietta, L. J. V., and Verkman, A. S. (2005) Small molecule correctors of defective ΔF508-CFTR cellular processing identified by high-throughput screening J. Clin. Invest. 115, 2564-2571 (Pubitemid 41266219)
12. Yoo, C. L., Yu, G. J., Yang, B., Robins, L. I., Verkman, A. S., and Kurth, M. J. (2008) 4?-Methyl-4,5?-bithiazole-based correctors of defective ΔF508-CFTR cellular processing Bioorg. Med. Chem. Lett. 18, 2610-2614 (Pubitemid 351503887)
13. Yu, G. J. (2009) Golden Bridge to Cystic Fibrosis: Heterocycles. Ph.D. dissertation; pp 93-116, Chapter 3, University of California, Davis.
14. Li, Z., Mintzer, E., and Bittman, R. (2006) First synthesis of free cholesterol-BODIPY conjugates J. Org. Chem. 71, 1718-1721
15. Song, A., Wang, X., and Lam, K. S. (2003) A convenient synthesis of coumarin-3-carboxylic acids via Knoevenagel condensation of Meldrums acid with ortho-hydroxyaryl aldehydes or ketones Tetrahedron Lett. 44, 1755-1758 (Pubitemid 36183393)
16. Mizukami, S., Watanabe, S., Hori, Y., and Kikuchi, K. (2008) Covalent protein labeling based on noncatalytic β -lactamase and a designed FRET substrate J. Am. Chem. Soc. 131, 5016-5017
17. Hantzsch, A. (1889) Thiazoles from thiamides Justus Liebigs Ann. Chem. 250, 257-273
18. Ye, L., Knapp, J. M., Sangwung, P., Fettinger, J. C., Verkman, A. S., and Kurth, M. J. (2010) Pyrazolylthiazole as ΔF508-cystic fibrosis transmembrane conductance regulator correctors with improved hydrophilicity compared to bithiazoles J. Med. Chem. 53, 3772-3781
19. Yang, H., Shelat, A. A., Guy, R. K., Gopinath, V. S., Ma, T., Du, K., Lukacs, G. L., Taddei, A., Folli, C., Pedemonte, N., Galietta, L. J., and Verkman, A. S. (2003) Nanomolar affinity small molecule correctors of defective Delta F508-CFTR chloride channel gating J. Biol. Chem. 278, 35079-35085 (Pubitemid 37102270)
20. Sheppard, D. N., Carson, M. R., Ostedgaard, L. S., Denning, G. M., and Welsh, M. J. (1994) Expression of cystic fibrosis transmembrane conductance regulator in a model epithelium Am. J. Physiol. 266, L405-13
21. Wang, D., Fan, J., Gao, X., Wang, B., Sun, S., and Peng, X. (2009) Carboxyl BODIPY dyes from bicarboxylic anhydrides: one-pot preparation, spectral properties, photostability, and biolabeling J. Org. Chem. 74, 7675-7683
22. Oushiki, D., Kojima, H., Terai, T., Arita, M., Hanaoka, K., Urano, Y., and Nagano, T. (2010) Development and application of a near-infrared fluorescence probe for oxidative stress based on differential reactivity of linked cyanine dyes J. Am. Chem. Soc. 132, 2795-2801
23. Mahmood, U. and Weissleder, R. (2003) Near-infrared optical imaging of proteases in cancer Mol. Cancer Ther. 2, 489-496